Democratic and Republican lawmakers alike worry the FDA may be backsliding on quality control just as it’s approving more generics.
“These are serious concerns that warrant further investigation, and we expect that the FDA will provide us with additional information and analysis,” said Oregon Representative Greg Walden, a top Republican on the Energy and Commerce Committee.
Representative Diana DeGette, a Colorado Democrat who chairs the House’s investigations subcommittee with oversight of the FDA, said regular and timely inspections are necessary to hold manufacturers accountable.
“Americans need to know that their medications are safe and effective,” said DeGette. “And it’s the FDA’s job to ensure that, from the factory floor to the shelves of our pharmacies.”
—With assistance from Jef Feeley
This article was provided by Bloomberg News.